Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Analytical validation of a psychiatric pharmacogenomic test.

Jablonski MR, King N, Wang Y, Winner JG, Watterson LR, Gunselman S, Dechairo BM.

Per Med. 2018 May 1;15(3):189-197. doi: 10.2217/pme-2017-0094. Epub 2018 Feb 7.

2.

Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Sewalia K, Watterson LR, Hryciw A, Belloc A, Ortiz JB, Olive MF.

Neuropharmacology. 2018 May 15;134(Pt A):36-45. doi: 10.1016/j.neuropharm.2017.11.034. Epub 2017 Nov 26.

3.

Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.

Simmons SJ, Gregg RA, Tran FH, Mo L, von Weltin E, Barker DJ, Gentile TA, Watterson LR, Rawls SM, Muschamp JW.

Addict Biol. 2018 Jan;23(1):102-110. doi: 10.1111/adb.12479. Epub 2016 Dec 1.

4.

Reinforcing Effects of Cathinone NPS in the Intravenous Drug Self-Administration Paradigm.

Watterson LR, Olive MF.

Curr Top Behav Neurosci. 2017;32:133-143. doi: 10.1007/7854_2016_33. Review.

PMID:
27431398
5.

Nicotine-induced behavioral sensitization in an adult rat model of attention deficit/hyperactivity disorder (ADHD).

Watterson E, Spitzer A, Watterson LR, Brackney RJ, Zavala AR, Olive MF, Sanabria F.

Behav Brain Res. 2016 Oct 1;312:333-40. doi: 10.1016/j.bbr.2016.06.050. Epub 2016 Jun 27.

6.

Sensitization to the motor stimulant effects of 3,4-methylenedioxypyrovalerone (MDPV) and cross-sensitization to methamphetamine in rats.

Watterson LR, Kufahl PR, Taylor SB, Nemirovsky NE, Olive MF.

J Drug Alcohol Res. 2016 May;5. pii: 235967. doi: 10.4303/jdar/235967.

7.

Effects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence.

Burrows BT, Watterson LR, Johnson MA, Olive MF.

J Drug Alcohol Res. 2015 Dec;4. pii: 235958. Epub 2015 Dec 29.

8.

Nicotine-induced place conditioning and locomotor activity in an adolescent animal model of attention deficit/hyperactivity disorder (ADHD).

Watterson E, Daniels CW, Watterson LR, Mazur GJ, Brackney RJ, Olive MF, Sanabria F.

Behav Brain Res. 2015 Sep 15;291:184-188. doi: 10.1016/j.bbr.2015.05.031. Epub 2015 May 22.

9.

Chronic stress enhanced fear memories are associated with increased amygdala zif268 mRNA expression and are resistant to reconsolidation.

Hoffman AN, Parga A, Paode PR, Watterson LR, Nikulina EM, Hammer RP Jr, Conrad CD.

Neurobiol Learn Mem. 2015 Apr;120:61-8. doi: 10.1016/j.nlm.2015.02.004. Epub 2015 Feb 27.

10.

Effects of α-pyrrolidinopentiophenone and 4-methyl-N-ethylcathinone, two synthetic cathinones commonly found in second-generation "bath salts," on intracranial self-stimulation thresholds in rats.

Watterson LR, Burrows BT, Hernandez RD, Moore KN, Grabenauer M, Marusich JA, Olive MF.

Int J Neuropsychopharmacol. 2014 Oct 31;18(1). pii: pyu014. doi: 10.1093/ijnp/pyu014.

11.

Baths salts, spice, and related designer drugs: the science behind the headlines.

Baumann MH, Solis E Jr, Watterson LR, Marusich JA, Fantegrossi WE, Wiley JL.

J Neurosci. 2014 Nov 12;34(46):15150-8. doi: 10.1523/JNEUROSCI.3223-14.2014. Review.

12.

Synthetic cathinones and their rewarding and reinforcing effects in rodents.

Watterson LR, Olive MF.

Adv Neurosci (Hindawi). 2014 Jun 4;2014:209875.

13.

The development of acamprosate as a treatment against alcohol relapse.

Kufahl PR, Watterson LR, Olive MF.

Expert Opin Drug Discov. 2014 Nov;9(11):1355-69. doi: 10.1517/17460441.2014.960840. Epub 2014 Sep 26. Review.

14.

Are AMPA receptor positive allosteric modulators potential pharmacotherapeutics for addiction?

Watterson LR, Olive MF.

Pharmaceuticals (Basel). 2013 Dec 30;7(1):29-45. doi: 10.3390/ph7010029.

15.

Positive or negative allosteric modulation of metabotropic glutamate receptor 5 (mGluR5) does not alter expression of behavioral sensitization to methamphetamine.

Kufahl PR, Nemirovsky NE, Watterson LR, Zautra N, Olive MF.

F1000Res. 2013 Mar 12;2:84. doi: 10.12688/f1000research.2-84.v1. eCollection 2013.

16.

The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts"

Watterson LR, Hood L, Sewalia K, Tomek SE, Yahn S, Johnson CT, Wegner S, Blough BE, Marusich JA, Olive MF.

J Addict Res Ther. 2012 Dec 1;Suppl 9. pii: 002.

17.

Abuse liability of novel 'legal high' designer stimulants: evidence from animal models.

Watterson LR, Watterson E, Olive MF.

Behav Pharmacol. 2013 Sep;24(5-6):341-55. doi: 10.1097/FBP.0b013e3283641ec8. Review.

18.

Safety and efficacy of acamprosate for the treatment of alcohol dependence.

Yahn SL, Watterson LR, Olive MF.

Subst Abuse. 2013;6:1-12. doi: 10.4137/SART.S9345. Epub 2013 Jan 31.

19.

Positive Allosteric Modulation of mGluR5 Accelerates Extinction Learning but Not Relearning Following Methamphetamine Self-Administration.

Kufahl PR, Hood LE, Nemirovsky NE, Barabas P, Halstengard C, Villa A, Moore E, Watterson LR, Olive MF.

Front Pharmacol. 2012 Nov 26;3:194. doi: 10.3389/fphar.2012.00194. eCollection 2012.

20.

Attenuation of reinstatement of methamphetamine-, sucrose-, and food-seeking behavior in rats by fenobam, a metabotropic glutamate receptor 5 negative allosteric modulator.

Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Hood LE, Olive MF.

Psychopharmacology (Berl). 2013 Jan;225(1):151-9. doi: 10.1007/s00213-012-2804-z. Epub 2012 Jul 21.

Supplemental Content

Loading ...
Support Center